What is he best known for?
The fields of study he is best known for:
Molecular biology, Diindolylmethane, 3,3'-Diindolylmethane, Biochemistry and Cancer cell are his primary areas of study.
His Molecular biology research is multidisciplinary, incorporating elements of Transfection, Receptor and Promoter, Response element, Sp1 transcription factor.
His 3,3'-Diindolylmethane research includes elements of Kinase and Mitochondrion.
His Biochemistry study typically links adjacent topics like Guinea pig.
Leonard F. Bjeldanes interconnects Cancer research, Cell growth and Cyclin-dependent kinase, Cell cycle, Apoptosis in the investigation of issues within Cancer cell.
His Estrogen receptor research is multidisciplinary, relying on both Endocrinology and Cyclin-dependent kinase 6.
His most cited work include:
- Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. (481 citations)
- Indole-3-carbinol Inhibits the Expression of Cyclin-dependent Kinase-6 and Induces a G1 Cell Cycle Arrest of Human Breast Cancer Cells Independent of Estrogen Receptor Signaling (246 citations)
- Lipoxin A4: a new class of ligand for the Ah receptor. (225 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Biochemistry, Cancer research, Internal medicine, Endocrinology and 3,3'-Diindolylmethane.
Biochemistry and Anticarcinogen are commonly linked in his work.
The various areas that Leonard F. Bjeldanes examines in his Cancer research study include Cell growth, Cancer cell, Cyclin-dependent kinase, Signal transduction and Estrogen receptor.
In his study, which falls under the umbrella issue of Estrogen receptor, Pharmacology is strongly linked to Agonist.
His study in 3,3'-Diindolylmethane is interdisciplinary in nature, drawing from both Molecular biology, Angiogenesis and Diindolylmethane.
His studies in Molecular biology integrate themes in fields like Receptor, Endogeny and Cell culture, Transfection.
He most often published in these fields:
- Biochemistry (31.58%)
- Cancer research (20.30%)
- Internal medicine (19.55%)
What were the highlights of his more recent work (between 2004-2014)?
- Cancer research (20.30%)
- Cancer cell (16.54%)
- 3,3'-Diindolylmethane (17.29%)
In recent papers he was focusing on the following fields of study:
Leonard F. Bjeldanes mainly focuses on Cancer research, Cancer cell, 3,3'-Diindolylmethane, Biochemistry and Indole-3-carbinol.
His studies deal with areas such as Endocrinology, Internal medicine, Signal transduction and Estrogen receptor, Estrogen receptor alpha as well as Cancer research.
The Internal medicine study combines topics in areas such as Cell growth and Phosphorylation.
His research integrates issues of Cell cycle, Kinase and Transfection in his study of Cancer cell.
He has included themes like Angiogenesis, Diindolylmethane and Immunology, Interferon gamma, Cytokine in his 3,3'-Diindolylmethane study.
His work carried out in the field of Biochemistry brings together such families of science as Luciferase and Aspergillus insulicola.
Between 2004 and 2014, his most popular works were:
- Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist (142 citations)
- 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. (123 citations)
- 3,3′-Diindolylmethane Is a Novel Mitochondrial H+-ATP Synthase Inhibitor that Can Induce p21Cip1/Waf1 Expression by Induction of Oxidative Stress in Human Breast Cancer Cells (106 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Cancer research, Cell biology, Biochemistry, Estrogen receptor alpha and Indole-3-carbinol.
Leonard F. Bjeldanes combines subjects such as Cell cycle checkpoint, Cell cycle, CDK inhibitor, Diindolylmethane and 3,3'-Diindolylmethane with his study of Cancer research.
In his work, Cancer cell is strongly intertwined with MAPK/ERK pathway, which is a subfield of Cell cycle checkpoint.
His Cell biology research incorporates themes from Molecular biology and Estrogen receptor beta.
He has researched Biochemistry in several fields, including Combinatorial chemistry and Tumor cells.
His p38 mitogen-activated protein kinases research integrates issues from Carcinogenesis, Endocrinology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
